Sign in
4

Changes in Ownership

Protagonist Therapeutics, Inc Filed Acc 0001104659-25-024062

Chief Financial Officer sold 24,903 shares at $58.73 ($1,462,553)

  • Chief Financial Officer acquired 24,903 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Ali Asif Chief Financial Officer 2025-03-12 Option exercise +15,203 $12.17 $185,021 78,024 D: show line 1 in the form
Ali Asif Chief Financial Officer 2025-03-12 Option exercise +9,700 $19.19 $186,143 87,724 D: show line 2 in the form
Ali Asif Chief Financial Officer 2025-03-12 Sale −24,903 $58.73 $1,462,553 62,821 D: show line 3 in the form
Open-market sales · 24,903 sh · avg $58.73 · $1,462,553

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Ali Asif Chief Financial Officer 2025-03-12 Option exercise · Stock Option (right to buy) −15,203 30,547 D: show line 4 in the form
Ali Asif Chief Financial Officer 2025-03-12 Option exercise · Stock Option (right to buy) −9,700 66,800 D: show line 5 in the form
Loading xslF345X05/tm259281-1_4seq1.xml…